Skip to main content

Table 4 Association of CYP2C19C*2 allele status with fatal and non-fatal cardiovascular events during follow-up

From: Cytochrome P450 2C19*2 polymorphism in patients with stable coronary heart disease and risk for secondary cardiovascular disease events: results of a long-term follow-up study in routine clinical care

 

Results of multivariable analysis

 

HR (95% CI) Adjusted for age and gender

HR (95% CI) *Adjusted for multiple covariates

CYP2C19C*2 Allele status

  

   GG

1 referent

1 referent

   AG

0.79 (0.54-1.17)

0.80 (0.52-1.23)

   AA

2.37 (1.20-4.68)

2.59 (1.27-5.28)

p for trend 0.66

p for trend 0.45

After exclusion of patients on clopidogrel or ticlopidin (n total = 963):

CYP2C19C*2 Allele status

  

   GG

1 referent

1 referent

   AG

0.82 (0.55-1.23)

0.87 (0.56-1.35)

   AA

2.18 (1.06-4.49)

2.27 (1.06-4.86)

p for trend 0.67

p for trend 0.42

  1. * adjusted for age, gender, BMI, school education, rehabilitation clinic, smoking status, history of diabetes mellitus, PCI, CABG, left ventricular function, HDL-cholesterol, LDL-cholesterol, treatment with lipid-lowering drugs, NT-proBNP.